< Back to previous page

Organisation

Therapeutic and Diagnostic Antibodies

Division

Lifecycle:1 Apr 2013 →  Today
Organisation profile:

Since over 25 years the laboratory focusses on the generation and characterization of monoclonal antibodies (Mabs), antibody derivatives, nanobodies and diabodies and application as either therapeutics, diagnostics or research tools.

Major research lines include:

  • Studies on structure-function relationship in proteins involved in cardiovascular disease (e.g.  Plasminogen Activator inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI))
  • Therapeutic drug monitoring and evaluation of immunogenicity with a particular focus on therapeutic monoclonal antibodies used in chronic inflammatory diseases (e.g. Inflammatory Bowel Disease (IBD) and Rheumatoid Arthritis (RA))
  • Development of a DNA-based platform for the in vivo expression of therapeutic monoclonal antibodies (mAbs).
Keywords:Monclonal Antibodies, Therapeutic Drug Monitoring, Gene Therapy
Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Pharmaceutics, Drug discovery and development